Sjogren's Syndrome Clinical Trials in Strasbourg
2 recruitingStrasbourg, France
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjogren's SyndromeSjogren DiseaseSjögren
Cullinan Therapeutics Inc.36 enrolled11 locationsNCT07041099
Recruiting
Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
Rheumatoid ArthritisSystemic Lupus ErythematosusGout+1 more
University Hospital, Strasbourg, France352 enrolled1 locationNCT05927688